T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment

Viviana Cobos Jiménez,Ferdinand W N M Wit,Maaike Joerink,Irma Maurer,Agnes M Harskamp,Judith Schouten,Maria Prins,Ester M M van Leeuwen,Thijs Booiman,Steven G Deeks,Peter Reiss,Neeltje A Kootstra,AGEhIV Study Group,P Reiss,F W N M Wit,M van der Valk,J Schouten,K W Kooij,R A Van Zoest,B C Elsenga,M Prins,M Martens,S Moll,J Berkel,M Totté,G R Visser,S Kovalev,S Zaheri,M M J Hillebregt,Y M C Ruijs,D P Benschop,P Reis,F R Janssen,M Heidenrijk,W Zikkenheiner,L Boumans,N A Kootstra,A M Harskamp-Holwerda,I Maurer,M M Mangas Ruiz,A F Girigorie,B Boeser-Nunnink,S E Geerlings,M H Godfried,A Goorhuis,J W R Hovius,F J B Nellen,J T M van der Meer,T van der Poll,J M Prins,W J Wiersinga,J van Eden,A M H van Hes,M Mutschelknauss,H E Nobel,F J J Pijnappel,A M Westerman,J de Jong,P G Postema,P H L T Bisschop,M J M Serlie,P Lips,E Dekker,S E J A de Rooij,J M R Willemsen,L Vogt,P Portegies,B A Schmand,G J Geurtsen,J A Ter Stege,M Klein Twennaar,B L F van Eck-Smit,M de Jong,D J Richel,F D Verbraak,N Demirkaya,I Visser,H G Ruhé,P T Nieuwkerk,R P van Steenwijk,E Dijkers,C B L M Majoie,M W A Caan,T Su,H W van Lunsen,M A F Nievaard,B J H van den Born,E S G Stroes,W M C Mulder

DOI: https://doi.org/10.1093/infdis/jiw146

2016-07-15

Abstract:Background: Aging-associated noncommunicable comorbidities are more prevalent among human immunodeficiency virus type 1 (HIV)-infected individuals than among HIV-uninfected individuals. Residual HIV-related chronic immune activation and senescence may increase the risk of developing comorbidities. Methods: Immune phenotyping, thymic output, and telomere length were assessed in 94 HIV-infected individuals who were aged >45 years and receiving antiretroviral therapy (ART; cases) and 95 age-matched uninfected controls. Results: Cases had lower CD4(+) T-cell counts, higher CD8(+) T-cell counts, and increased levels of immune activation (ie, increased soluble CD14 [sCD14] level and increased percentages of CD38(+)HLA-DR(+) cells among both CD4(+) and CD8(+) T cells), regulatory T cells, and percentage of programmed cell death 1 (PD-1)-expressing cells among CD4(+) T cells. Immune senescence levels (ie, percentages of CD27(-)CD28(-) cells or CD57(+) cells) were comparable between cases and controls. Peripheral blood mononuclear cells from cases had shorter telomeres but increased single-joint T-cell receptor excision circle content and CD31(+) naive CD4(+) T cells. Although cytomegalovirus (CMV) antibody titers were higher in cases, CMV-specific T-cell responses were comparable between cases and controls. T-cell senescence in cases was independently associated with T-cell activation but not with CMV-specific immune responses. Conclusions: Despite long-term receipt of ART, HIV-infected adults had higher levels of immune activation, regulatory T cells, and PD-1-expressing CD4(+) cells and shorter telomeres. The increased soluble CD14 levels and percentage of CD38(+)HLA-DR(+) cells among CD4(+) T cells correlated with shorter telomeres and increased regulatory T-cell levels. This suggests that HIV influences immune function irreversibly, with several pathways that are persistently abnormal during effective ART. Therapies aimed at improving immune health during ART are needed.